Denise Garner

PharmD, MS

MANAGER, VALUE EVIDENCE

Chapel Hill, NC

No act of kindness, no matter how small, is ever wasted."- Aesop

Areas of Expertise

  • Patient Experience Data
  • Data Analysis
  • Project Management

Biography

Denise Garner is a manager in Value Evidence. Previously, she completed the Health Outcomes and Market Access Fellowship at AESARA and the University of North Carolina Eshelman School of Pharmacy after graduating with her Doctor of Pharmacy degree from University of Wisconsin – Madison. During the fellowship he performed health outcomes research with faculty in the Divisions of Pharmaceutical Outcomes and Policy and Practice Advancement and Clinical Education.

Denise has collaborated with a multitude of pharma clients and gained experience in patient experience data, payer research, AMCP dossier writing, systematic literature reviews, and HEOR and Value Access Benchmarking.

Key publications

  • Cha-Silva AS, Gavaghan M, Bergroth T, Alexander-Parrish R, Yang J, Draica F, Patel J, Garner DA, Stanford RH, Meier G, McLaughlin JM, Nguyen JL. Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review. Am J Ther. (Forthcoming).
  • Branchford B, Clark K, Stanford RH, Garner DA, Huang SP, Wolford E. Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers. Blood Coagul Fibrinolysis. Published online February 22, 2024. doi:10.1097/MBC.0000000000001275
  • Clark K, Garner DA, Wu A, Mody L, Patel J, Branchford B. Disease Burden, Quality of Life, and Treatment Patterns in Patients with Hereditary Factor X Deficiency: Analysis of Data from the Hereditary Factor X Deficiency in America Survey. In: Thrombosis & Hemostasis Summit of North America; April 4-6, 2024, Chicago IL.
  • Clark K, Wu A, Garner DA, Mody L, Patel J, Branchford B. Burden of Disease and Impact on Quality of Life in Hereditary Factor X Deficiency Patients Who Were Diagnosed at Birth: Findings from the Hereditary Factor X Deficiency in America Survey. In: Thrombosis & Hemostasis Summit of North America; April 4-6, 2024, Chicago IL.
  • Foss K, Henderson G, Milko L, O’Daniel J, Garner DA, Roberts M. Learning from each other: Understanding strategies to increase the reach and representativeness of population genetic screening. In: 16th Annual Conference on the Science of Dissemination and Implementation; December 10-13, 2023, Arlington, VA.
  • Patel C, Hogue S, Garner DA, Riley P, Masseria C. The Price Is Right or Is It? Navigating the Inflation Reduction Act (IRA) with Payer Perspectives on Evidence Needs, Fair Market Pricing and Patient Access Implications. In ISPOR Europe; November 12-15, 2023, Copenhagen, Denmark.
  • Garner DA, Ngo P, Roberts M. Exploring Awareness and Perceptions of Genetic Testing for Cancer Risk. In: AMCP Nexus; October 16-19, 2023, Orlando, FL.
  • Higgins CR, Lee YF, Garner DA, Jayakumar A, Lie GT, Ozawa S. Access to Abortion Medications Online in the Post Roe v. Wade Era. In: AMCP Nexus; October 16-19, 2023, Orlando, FL. Bronze Ribbon Awarded.
  • Cha-Silva AS, Gavaghan M, Nguyen J, Alexander-Parrish R, Yang J, Patel J, Garner D, Stanford R, Meier G. Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death. In: ID WEEK 2023; October 11-15, 2023, Boston, MA.
  • Garner DA, Clark K, Huang S, Stanford RH, Branchford B. Burden of Disease and Impact on Quality of Life in Hereditary Factor X Deficiency Patients Receiving Prophylaxis: Findings From the Hereditary Factor X Deficiency in America Survey. In: Hemostasis & Thrombosis Research Society; March 10-12, 2023, Orlando, FL.

AESARA Scholar Program

UNC FELLOW – Class 2024

Education

  • PharmD, University of Wisconsin – Madison
  • MS in Biomedical and Health Informatics, University of North Carolina – Chapel Hill
  • BS, Iowa State University

My letter

Just as gamma signifies ongoing change and growth with its circular shape, our work revolves around navigating the dynamic landscape of healthcare systems and evolving regulatory environments. We embody the spirit of continual transformation, helping pharmaceutical companies adapt and thrive amidst shifting market dynamics. Like gamma, we embrace the complexity of reality and leverage it to drive positive change, ensuring that our strategies and solutions evolve alongside the needs of patients, payers, and healthcare providers.

Contact us

Fill out the form below, and we will be in touch shortly.